Supplementary data

Published: 14-08-2019| Version 1 | DOI: 10.17632/6m4ghzt666.1
Da-Ae Yu


Supplementary data for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and meta-analysis. Supplemental Fig 1. PRISMA flow diagram. Supplemental Table I. Main characteristics of studies on oral tofacitinib and ruxolitinib for the treatment of alopecia areata Supplemental References